Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group

Cited by (245)

Items 101–200 of 245

1. The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment
   Agnieszka E. Zając, Anna Malgorzata Czarnecka, Piotr Lukasz Rutkowski · 2023 · Cancers
2. Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis
   Peter Múdrý, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo, Marta Ježová, Tomáš Tomáš, Jaroslav Štěrba · 2021 · Journal of bone oncology
3. State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma
   Cristina Meazza, Sebastian Dorin Asaftei · 2021 · Expert Opinion on Pharmacotherapy
4. Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis
   Haiyong Ren, Hengyuan Li, Tao Xie, Ling Sun, Ting Zhu, Sheng Dong Wang, Zhao Ming Ye, Yinhua Zhang · 2016 · OncoTargets and Therapy
5. Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment
   Karthik Venkatakrishnan, Yi Liu, Dennis A. Noe, Jaime Mertz, Michael Bargfrede, Thomas C Marbury, Kambiz Farbakhsh, Cristina Oliva, Ashley Milton · 2013 · British Journal of Clinical Pharmacology
6. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma
   Roelof van Ewijk, Nikolas Herold, Fredrik Baecklund, Daniel Baumhoer, Kjetil Boye, Nathalie Gaspar, Semi Harrabi, Lianne Haveman, Stefanie Hecker‐Nolting, Laura S. Hiemcke‐Jiwa et al. · 2023 · EJC Paediatric Oncology
7. Advances in Therapy for Pediatric Sarcomas
   Aaron R. Weiss, Jonathan Benjamin Gill, John Goldberg, Joanne Lagmay, Holly L. Spraker‐Perlman, Rajkumar Venkatramani, Damon R. Reed · 2014 · Current Oncology Reports
8. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging
   Liping Wang, Peipei Li, Xue Xiao, Jingying Li, Juan Li, Huanghao Yang, Weihong Tan · 2018 · Talanta
9. Multi-Constrained Joint Non-Negative Matrix Factorization with Application to Imaging Genomic Study of Lung Metastasis in Soft Tissue Sarcomas
   Jin Deng, Weiming Zeng, Wei Kong, Yuhu Shi, Xiaoyang Mou, Jian Ping Guo · 2019 · IEEE Transactions on Biomedical Engineering
10. What is the best clinical approach to recurrent/refractory osteosarcoma?
    Cristina Meazza, Stefano Bastoni, Paolo Scanagatta · 2020 · Expert Review of Anticancer Therapy
11. Animal models of osteosarcoma
    Timothy M. Fan · 2010 · Expert Review of Anticancer Therapy
12. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials
    Xiaojie Wang, Hong Zheng, Tao Shou, Chunming Tang, Kun Miao, Ping Wang · 2017 · Journal of Orthopaedic Surgery and Research
13. Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
    Binghao Li, Guoqi Li, Xiaobo Yan, Dan Zhu, Patrick P. Lin, Zenan Wang, Hao Qu, Xuexin He, Yanbiao Fu, Xiuliang Zhu et al. · 2021 · Clinical Cancer Research
14. MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo
    Liang Ge, Baisong Zheng, Minghe Li, LIANG NIU, Zhihong Li · 2016 · Oncology Letters
15. Re-calculating! Navigating through the osteosarcoma treatment roadblock
    Jeremy McGuire, Thomas J. Utset‐Ward, Damon R. Reed, Conor C. Lynch · 2016 · Pharmacological Research
16. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis
    Rui Gu, Yifu Sun · 2018 · Journal of Cancer Research and Therapeutics
17. Participation of the Fas/FasL Signaling Pathway and the Lung Microenvironment in the Development of Osteosarcoma Lung Metastases
    Gangxiong Huang, Kazumasa Nishimoto, Yuanzheng Yang, Eugenie S. Kleinerman · 2014 · Advances in experimental medicine and biology
18. Immunotherapy in Pediatric Solid Tumors—A Systematic Review
    Raoud Marayati, Colin H. Quinn, Elizabeth Ann Beierle · 2019 · Cancers
19. Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer
    Danh D. Truong, Salah-Eddine Lamhamedi-Cherradi, Joseph Aloysius Ludwig · 2022 · Journal of bone oncology
20. Variability in the reported management of pulmonary metastases in osteosarcoma
    Onita Bhattasali, Andrea T. Vo, Michael E. Roth, David Geller, Robert Lor Randall, Richard Greg Gorlick, Jonathan Benjamin Gill · 2015 · Cancer Medicine
21. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
    Yang Qu, Shanyong Zhang, Mingyang Kang, Rongpeng Dong, Jianwu Zhao · 2015 · Oncology Reports · Retracted
22. Pulmonary Metastasectomy in Pediatric Solid Tumors
    Nicole J. Croteau, Todd E. Heaton · 2019 · Children
23. Mechanisms of therapy resistance in osteosarcoma: a review
    Jantine PosthumaDeBoer, Barend J. van Royen, Marco N. Helder · 2013 · Oncology Discovery
24. Proteomics of osteosarcoma
    Giulia Bernardini, Marcella Laschi, Michela Geminiani, Annalisa Santucci · 2014 · Expert Review of Proteomics
25. Immunotherapy in Sarcoma: Future Horizons
    Melissa Amber Burgess, Vikram C. Gorantla, Kurt Richard Weiss, Hussein A. Tawbi · 2015 · Current Oncology Reports
26. FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
    Carl T. Gustafson, Tewodros Mamo, Kristen L. Shogren, Avudaiappan Maran, Michael J. Yaszemski · 2017 · Frontiers in Pharmacology
27. Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation
    Shaojie Jiang, Fei Zhou, Yanhua Zhang, Weiping Zhou, Linghua Zhu, Miaofeng Zhang, Jingfeng Luo, Rui Ma, Xiufang Xu, Jiying Zhu et al. · 2020 · Journal of Cancer
28. Recent advances in understanding osteosarcoma and emerging therapies
    Nathalie Gaspar, Maria Eugénia Marques Da Costa, Olivia Fromigué, Robin Droit, Pablo Berlanga, Antonin Marchais · 2020 · Faculty Reviews
29. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules
    Antonella Grigoletto, Tommaso Tedeschini, Elena Canato, Gianfranco Pasut · 2020 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
30. Osteosarcoma: Time to move on?
    Stefan Bielack · 2010 · European Journal of Cancer
31. Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
    Clément J. F. Heymann, Christine Bobin‐Dubigeon, Javier Muñoz-García, Denis Cochonneau, Emilie Ollivier, Marie‐Françoise Heymann, Dominique Heymann · 2022 · Journal of bone oncology
32. Children's Oncology Group's 2023 blueprint for research: Bone tumors
    Damon R. Reed, Patrick Joseph Grohar, Elyssa M. Rubin, Odion T. Binitie, Mark Krailo, Jessica L. Davis, Steven G. DuBois, Katherine A. Janeway · 2023 · Pediatric Blood & Cancer
33. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway
    Guangfu Chen, Min Wang, Xiang Liu · 2019 · Molecular Medicine Reports
34. Incremental improvement in osteosarcoma chemotherapy?
    Scott M. Schuetze · 2017 · Annals of Oncology
35. Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy
    Aurélie Dutour, Michela Pasello, Luke Farrow, Mahetab H. Amer, Natacha Entz‐Werlé, Michaela Nathrath, Katia Scotlandi, Sibylle Mittnacht, Anne Gomez‐Brouchet · 2025 · Cancer and Metastasis Reviews
36. The selective inhibitor of nuclear export ( SINE ) verdinexor exhibits biologic activity against canine osteosarcoma cell lines
    Justin T. Breitbach, Darian S. Louke, Savannah J. Tobin, Mauria R. Watts, Alexander E. Davies, Joelle M. Fenger · 2021 · Veterinary and Comparative Oncology
37. Fusion of FDG-PET Image and Clinical Features for Prediction of Lung Metastasis in Soft Tissue Sarcomas
    Jin Deng, Weiming Zeng, Yuhu Shi, Wei Kong, Shunjie Guo · 2020 · Computational and Mathematical Methods in Medicine
38. Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom
    Alexandre Pérez-López, Cristina Martín‐Sabroso, Ana Isabel Torres‐Suárez, Juan Aparicio-Blanco · 2020 · Pharmaceutics
39. Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
    David Barnes, Peter Dutton, Øyvind Sverre Bruland, Hans A. J. Gelderblom, Ade Faleti, Claudia Bühnemann, Annemiek M. van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love et al. · 2022 · BMC Cancer
40. Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape
    Jacopo Uliano, Eleonora Nicolò, Carla Corvaja, Beatrice Taurelli Salimbeni, Dario Trapani, Giuseppe Curigliano · 2022 · Expert Review of Clinical Pharmacology
41. Fifteen Years' Experience of the Brazilian Osteosarcoma Treatment Group (BOTG): A Contribution from an Emerging Country
    Antônio Sérgio Petrilli, Algemir Lunardi Brunetto, Mônica Cypriano, Alexandre Archanjo Ferraro, Carla Renata Pacheco Donato Macedo, Andreza Almeida Senerchia, Maria Teresa Almeida, Cecília Maria Lima da Costa, Daniel Lustosa, Maria Luisa Borsato et al. · 2013 · Journal of Adolescent and Young Adult Oncology
42. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study
    Caroline Brard, Lisa V. Hampson, Nathalie Gaspar, Marie‐Cécile Le Deley, Gwénaël Le Teuff · 2019 · BMC Medical Research Methodology
43. Applying Osteosarcoma Immunology to Understand Disease Progression and Assess Immunotherapeutic Response
    Hillary G. Pratt, E. Markel Justin, Brock A. Lindsey · 2020 · Advances in experimental medicine and biology
44. PRRX1 promotes malignant properties in human osteosarcoma
    Ryoji Joko, Daisuke Yamada, Masahiro Nakamura, Aki Yoshida, Shota Takihira, Tomoka Takao, Ming Lu, Kohei Sato, Tatsuo Ito, Toshiyuki Kunisada et al. · 2020 · Translational Oncology
45. Surface expression of the immunotherapeutic target GD2 in osteosarcoma depends on cell confluency
    Malena Wiebel, Sareetha Kailayangiri, Bianca Altvater, Jutta Meltzer, Kay Grobe, Sabine Kupich, Claudia Rössig · 2021 · Cancer Reports
46. Osteosarcoma in Korean children and adolescents
    Jun Ah Lee · 2015 · Korean Journal of Pediatrics
47. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway
    Liang Tang, Dong Wang, Dongyun Gu · 2018 · Pathology & Oncology Research · Retracted
48. The Efficiency and Toxicity of Mifamurtide in Childhood Osteosarcoma
    Nurdan Taçyıldız, Sonay İncesoy Özdemir, Emel Ünal, Melda Berber Hamamcı, Handan Ugur Dincaslan, Gülsan Yavuz · 2018 · Journal of Pediatric Hematology/Oncology
49. Osteosarcoma
    Patrick P. Lin, SHREYASKUMAR R. PATEL · 2012 · Springer eBooks
50. Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma
    Kang-Wen Xiao, Zhibo Liu, Zihang Zeng, Feifei Yan, Lingfei Xiao, Jia-Li Li, Lin Cai · 2021 · Journal of Oncology
51. Natural product derived immune-regulatory agents
    James E. Talmadge · 2016 · International Immunopharmacology
52. Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2
    Nicola J. Mason, Laura Elizabeth Selmic, Audrey Ruple, Cheryl A. London, Lisa G. Barber, Kristen M. Weishaar, James A. Perry, Jennifer Mahoney, Brian K. Flesner, Jeffrey N. Bryan et al. · 2025 · Molecular Therapy
53. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma
    Awf A. Al-Khan, Judith S. Nimmo, Mourad Tayebi, Stewart D. Ryan, James O. Simcock, Raboola Tarzi, Charles A. Kuntz, Eman Saad, Michael J. Day, Samantha J. Richardson et al. · 2020 · Scientific Reports
54. von Willebrand factor promotes platelet-induced metastasis of osteosarcoma through activation of the VWF-GPIb axis
    Q. Wang, Wenyi Liu, Jianhui Fan, Jiong Jiong Guo, F. Shen, Zhengliang Ma, Changgeng Ruan, Ling Guo, Miao Jiang, Yiming Zhao · 2020 · Journal of bone oncology
55. Metastasis-Initiating Osteosarcoma Subpopulations Establish Paracrine Interactions with Lung and Tumor Cells to Create a Metastatic Niche
    James Brandon Reinecke, Leyre Jimenez Garcia, Amanda J. Saraf, John Hinckley, Amy C. Gross, Hélène Le Pommellet, Kelly M. Gutpell, Maren Cam, Matthew V. Cannon, Matthew J. Gust et al. · 2025 · Cancer Research
56. Targeted therapy for soft tissue sarcomas in adolescents and young adults
    Diana A. Steppan, Christine A. Pratilas, David Mark Loeb · 2017 · Adolescent Health Medicine and Therapeutics
57. Current treatment landscape and emerging management options for extremity sarcoma
    Siddharth Turkar · 2018 · Cancer Research Statistics and Treatment
58. Survival outcomes and surgical morbidity based on surgical approach to pulmonary metastasectomy in pediatric, adolescent and young adult patients with osteosarcoma
    Christopher Kuo, Jemily Malvar, Yueh‐Yun Chi, Eugene S. Kim, Rachana Shah, Fariba Navid, James E. Stein, Leo Mascarenhas · 2023 · Cancer Medicine
59. Zebrafish as a Model for Human Osteosarcoma
    Alexander B. Mohseny, Pancras C.W. Hogendoorn · 2014 · Advances in experimental medicine and biology
60. Peptide and protein based pharmaceuticals
    Gábor Mező · 2013 · Royal Society of Chemistry eBooks
61. Immune Therapy for Sarcomas
    Peter Meade Anderson · 2017 · Advances in experimental medicine and biology
62. Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227
    Peter Meade Anderson, Vivek Subbiah, Matteo Maria Trucco · 2022 · Frontiers in Medicine
63. Myeloid Cells in the Immunosuppressive Microenvironment as Immunotargets in Osteosarcoma
    Cyrus J. Sholevar, Natalie M Liu, Tasneem Mukarrama, Jinhwan Kim, Jessica Lawrence, Robert J. Canter · 2025 · ImmunoTargets and Therapy
64. Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives
    Giuseppe Badalamenti, Carlo G. M. Messina, Ida De Luca, Emmanuela Musso, Alessandra Casarin, Lorena Incorvaia · 2018 · La radiologia medica
65. A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma
    Elizabeth Fox, Christine M. Busch, Alexander DeBernardo, Blair Segers, Joseph Gottschalk, Richard B. Womer, Naomi Balamuth, Rochelle Bagatell, Frank M. Balis · 2021 · Cancer Chemotherapy and Pharmacology
66. YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
    ZHUO ZHANG, Lianjun Ma, Jincheng Wang · 2015 · Oncology Reports
67. Roles of Parathyroid Hormone-Related Protein (PTHrP) and Its Receptor (PTHR1) in Normal and Tumor Tissues: Focus on Their Roles in Osteosarcoma
    Awf A. Al-Khan, Noora Al Balushi, Samantha J. Richardson, Janine A. Danks · 2021 · Frontiers in Veterinary Science
68. SC‐1, a sorafenib derivative, shows anti‐tumor effects in osteogenic sarcoma cells
    Chen‐Ti Wang, Chen‐Si Lin, Chung‐Wai Shiau, Pei‐Yi Chu, Chung-Ching Hsiao, Yi-Lun Chiang, Wei‐Tien Tai, Kuen‐Feng Chen · 2012 · Journal of Orthopaedic Research®
69. Tissue microarray staining reveals PLD1 and Sp1 have a collaborative, pro-tumoral effect in patients with osteosarcomas
    Xiaoxu Wang, Ying Liao, Hong Liang, Zhi Zeng, Tangbo Yuan, Xue Xia, Jian Qin · 2017 · Oncotarget
70. Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene
    Patrick J. Messerschmitt, Ashley N. Rettew, Nicholas O. Schroeder, Robert E. Brookover, Avanti Jakatdar, Patrick J. Getty, Edward M. Greenfield · 2012 · Sarcoma
71. CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis
    Yunmi Ko, Seog-Yun Park, Jong Woong Park, June Hyuk Kim, Hyun Guy Kang, Jun Ah Lee · 2024 · Cells
72. Chemotherapy Regimens for Patients with Newly Diagnosed Malignant Bone Tumors
    Ryan David Roberts, Mary Frances Wedekind, Bhuvana A. Setty · 2015 · Pediatric oncology
73. HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies
    David S Geller, Richard Greg Gorlick · 2009 · Expert Opinion on Pharmacotherapy
74. Emerging cytokine networks in osteosarcoma
    Luís Carlos Lopes‐Júnior, Denise Sayuri Calheiros da Silveira, Anderson Vulczak, Jéssica Cristina dos Santos, Luciana Chain Veronez, Andressa Fisch, Milena Flória‐Santos, Regina Aparecida Garcia de Lima, Gabriela Pereira da Silva · 2016
75. Controversies and Challenges in the Management of Osteosarcoma—an Indian Perspective
    Abhenil Mittal, Deepam Pushpam, Shuvadeep Ganguly, Venkatesan Sampath Kumar, Shah Alam Khan, Sameer Bakhshi · 2022 · Indian Journal of Surgical Oncology
76. Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta‐Analysis
    Tao Zhang, Song Zhang, Feifei Yang, Lili Wang, Si-gang ZHU, Bing Qing Qiu, Shunhua Li, Zhongliang Deng · 2017 · Journal of Cellular Biochemistry
77. Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review
    Robert Koucheki, Aaron Gazendam, Jonathan R. Perera, Anthony Michael Griffin, Peter Charles Ferguson, Jay Steven Wunder, Kim M. Tsoi · 2021 · Current Oncology
78. Fifty Years of Advances in Sarcoma Treatment: Moving the Needle from Conventional Chemotherapy to Targeted Therapy
    SHREYASKUMAR R. PATEL · 2014 · American Society of Clinical Oncology Educational Book
79. New drugs in sarcomas
    Juan Martín-Liberal, Charlotte Benson, Ian Robert Judson · 2013 · Expert Opinion on Pharmacotherapy
80. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement
    Samson Lalhmangaihzuala, Khiangte Vanlaldinpuia, Vanlalngaihawma Khiangte, Zathang Laldinpuii, Thanhming liana, Chhakchhuak Lalhriatpuia, Zodinpuia Pachuau · 2024 · Molecular Diversity
81. Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma
    James Brandon Reinecke, Ryan David Roberts · 2020 · Advances in experimental medicine and biology
82. Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA
    Yiying Bian, Jintao Huang, Ziliang Zeng, Hao Yao, Jian Tu, Bo Wang, Yutong Zou, Xianbiao Xie, Jingnan Shen · 2022 · Annals of Translational Medicine
83. Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience
    Nurdan Taçyıldız, Emel Ünal, Handan Ugur Dincaslan, Hatice Mine Çakmak, Kenan Köse, Hikmet Gülşah Tanyıldız, Ömer Kartal · 2020 · Asian Pacific Journal of Cancer Prevention
84. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis
    Stefania Kokkali, Ioannis Kotsantis, Elpida Magou, Sofia Talagani, Theodoros Kormas, Giakoumis Diakoumis, Nikolaos Spathas, Amanda K. Psyrri, Alexandros S Ardavanis · 2022 · Investigational New Drugs
85. Evaluating the Outcome and Patient Safety of Methotrexate, Doxorubicin, and Cisplatin Regimen for Chemotherapy in Osteosarcoma: A Meta-Analysis
    Mohamad Ismail, I Gede Eka Wiratnaya, Risang Haryo Raditya · 2024 · Asian Pacific Journal of Cancer Prevention
86. Immunotherapeutic Intervention against Sarcomas
    Paolo Pedrazzoli, Simona Secondino, Vittorio Perfetti, Patrizia Comoli, Daniela Montagna · 2011 · Journal of Cancer
87. Past, Present and Future of Therapies in Pediatric Sarcomas
    Pooja Hingorani, Edward Anders Kolb · 2010 · Future Oncology
88. Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis
    Hyun Jin Song, Jun Ah Lee, Euna Han, Eui‐Kyung Lee · 2015 · Tumor Biology
89. Improving positioning of 3D-printed surgical guides using image-processing techniques
    Emilio A. Ramírez, Carlos G. Helguero, Jorge Amaya, Vamiq M. Mustahsan, David E. Komatsu, Fazel A. Khan, Imin Kao · 2017 · IEEE Ecuador Technical Chapters Meeting (ETCM)
90. The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma
    Guisen Lai, Xinyi Zhao, Yuanquan Chen, Tianwei Xie, Zepeng Su, Jiajie Lin, Keng Chen, Keng Chen · 2025 · International Immunopharmacology
91. Macrophage and osteosarcoma cell crosstalk is dependent on oxygen tension and 3D culture
    Katherine H. Griffin, Isabel S. Sagheb, Thomas P. Coonan, Fernando A. Fierro, Robert Lor Randall, Jonathan Kent Leach · 2024 · Biomaterials Advances
92. Sarcomas of Bone
    Megan E. Anderson, Steven G. DuBois, Mark C. Gebhardt · 2020 · Elsevier eBooks
93. The Warburg Trap: A Novel Therapeutic Approach for Targeting Osteosarcoma
    Jörg Fellenberg, Sarina Losch, Elena Tripel, Burkhard Lehner, Svitlana Melnik · 2023 · Cells
94. New treatment options for nonmetastatic osteosarcoma: focus on mifamurtide in adolescents
    Winston W. Huh, Egas-Bejar, Pete M. Anderson · 2012 · Clinical Oncology in Adolescents and Young Adults
95. Sarcoma Immunotherapy
    Launce G. Gouw, Kevin B. Jones, Sunil Sharma, Robert Lor Randall · 2011 · Cancers
96. Maintenance therapy for pediatric sarcoma: full throttle ahead?
    Nadège Corradini, Nicolás André, Daniel H. Orbach · 2025 · Current Opinion in Oncology
97. Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report
    Andrew S. Fang, Lee Jae Morse, Rosanna L. Wustrack, Ryan Huber, Minggui Pan · 2020 · The Permanente Journal
98. The Role of Adenosine in Overcoming Resistance in Sarcomas
    Marlid Cruz‐Ramos, Sara Aileen Cabrera-Nieto, Mario Murguía‐Pérez, Fernanda Sarahí Fajardo-Espinoza · 2024 · International Journal of Molecular Sciences
99. Targeting the Tumor Microenvironment in Osteosarcoma: A Pathway to Overcome Therapeutic Resistance
    Kaniga Pandi, Binoy Varghese Cheriyan, Rithika Sooriyaprakash, Pradhosh Sakthivel, Rajeshkumar Thirupathi · 2024 · Biomedical & Pharmacology Journal
100. Multidisciplinary sarcoma care
     Raphael E. Pollock, Jason E. Payne, Alan D. Rogers, Stephen J. Smith, Obiajulu Hans Iwenofu, Ian Lee Valerio, Terri A. Zomerlei, John Harrison Howard, David Dornbos, Michael Anthony Galgano et al. · 2018 · Current Problems in Surgery